Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LFST
BuyPremium GrowerFLAGLifeStance Health Group, Inc. · Healthcare · United States · $4.7B · Avg Vol: $62M/d
Insufficient evidence for a screen-pass. LifeStance Health Group, Inc.: fails the quant gate on value (Q58/V30/M88; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
COMPANY DESCRIPTION
LifeStance Health Group, Inc. is one of the largest U.S. providers of outpatient mental health services, offering a comprehensive range of psychiatric and therapy services across multiple states. The company addresses the growing demand for accessible mental healthcare through a network of employed and affiliated clinicians, leveraging technology for both in-person and telehealth appointments. Its scale and integrated care model position it as a significant player in the rapidly expanding behavioral health market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 859.5M | 1.1B | 1.3B | 1.4B | 18.3% | 1.6B | 1.7B | 2.0B | 17.1% |
| EPS | -0.61 | -0.51 | -0.15 | 0.03 | — | 0.13 | 0.05 | — | 70.8% |
| Shares | 376.0M | 378.7M | 382.7M | 388.3M | +3.3% | 382.1M | — | — | — |
| Debt | 476.5M | 511.0M | 485.2M | 474.5M | -0.1% | 474.2M | — | — | — |
| Equity | 1.5B | 1.4B | 1.4B | 1.5B | 0.1% | — | — | — | — |
| Op CF | 52.8M | -16.9M | 107.3M | 146.2M | 40.4% | 217.9M | — | — | — |
| Inv CF | -139.5M | -60.3M | -21.6M | -36.1M | — | — | — | — | — |
| Fin CF | 47.3M | 47.4M | -9.9M | -16.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LFST are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LFST | LifeStance Health Group, Inc.(you) | $4.7B | 80 | Buy |
| PACS | PACS Group, Inc. | $6.8B | 74 | Buy |
| CON | Concentra Group Holdings Parent, Inc. | $4.4B | 93 | Strong Buy |
| CHE | Chemed Corporation | $6.8B | 89 | Strong Buy |
| OPCH | Option Care Health, Inc. | $3.6B | 68 | Buy |
| NHC | National HealthCare Corporation | $3.5B | 92 | Strong Buy |
| ASTH | Astrana Health, Inc. | $1.9B | 83 | Strong Buy |
| UHS | Universal Health Services, Inc. | $10.1B | 89 | Strong Buy |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.9B | 96 | Strong Buy |
| GRDN | Guardian Pharmacy Services, Inc. | $2.3B | 93 | Strong Buy |
Peer medians: ROE -30.2% · P/E 26.9x · Gross margin 58.3%